Thursday, July 26, 2018

Amgen Revises Guidance - Quick Facts

Amgen (AMGN) announced, for the full year 2018, the company now expects: on a non-GAAP basis, EPS in the range of $13.30 to $14.00. Previously, the company expected non-GAAP EPS in the range of $12.80 to $13.70. The company expects total revenues in the range of $22.5 billion to $23.2 billion. Previously, the company expected total revenues in the range of $21.9 billion to $22.8 billion.

from RTT - Earnings https://ift.tt/2mHUBiS
via IFTTT

No comments:

Post a Comment